高级检索
当前位置: 首页 > 详情页

Efficacy of scopolamine plus propofol in the treatment of recalcitrant psoriasis: A pilot study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Anesthesiol, Shanghai 200020, Peoples R China [2]Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Curat Anesthesia,LuWan Branch, Shanghai, Peoples R China [3]Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, Dept Dermatol, Shanghai, Peoples R China
出处:
ISSN:

关键词: antagonism cholinergic neurotransmission propofol recalcitrant psoriasis scopolamine

摘要:
Accumulating evidence suggests that botulinum neurotoxins (BoNTs), which inhibit acetylcholine release, can be used for treating plaque psoriasis. The therapeutic effects of scopolamine occur through antagonism of central muscarinic acetylcholine receptors. Thus, scopolamine has potential for the treatment of psoriasis. We aimed to evaluate the efficacy and safety of scopolamine plus propofol for the treatment of recalcitrant psoriasis. Twelve patients with recalcitrant psoriasis were enrolled. Patients received intravenous injection of scopolamine plus propofol for 5 consecutive days per month for a total of 3 months. Clinical efficacy was evaluated using a Psoriasis Area and Severity Index (PASI) score. Efficacy outcome was >= 75% reduction in PASI score (PASI75) from baseline. Two patients were lost to follow-up. At week 8, two of 10 patients (20%) achieved PASI75, and at week 12, seven of 10 (70%) achieved PASI75. Treatment was well tolerated, with no reported adverse events. Our study revealed the efficacy and safety of scopolamine plus propofol for the treatment of recalcitrant psoriasis. Scopolamine plus propofol therapy may be a new treatment for recalcitrant psoriasis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 皮肤病学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 皮肤病学
JCR分区:
出版当年[2019]版:
Q2 DERMATOLOGY
最新[2024]版:
Q1 DERMATOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Anesthesiol, Shanghai 200020, Peoples R China [2]Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Curat Anesthesia,LuWan Branch, Shanghai, Peoples R China
通讯作者:
通讯机构: [1]Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Anesthesiol, Shanghai 200020, Peoples R China [*1]Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200020, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:28508 今日访问量:0 总访问量:1584 更新日期:2025-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)